(19)
(11) EP 3 624 834 A1

(12)

(43) Date of publication:
25.03.2020 Bulletin 2020/13

(21) Application number: 17731332.7

(22) Date of filing: 17.05.2017
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 16/40(2006.01)
 A61K 35/15(2015.01)
(86) International application number:
PCT/US2017/033039
(87) International publication number:
WO 2018/212770 (22.11.2018 Gazette 2018/47)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(71) Applicant: Thunder Biotech Inc.
Alpine, Utah 84004 (US)

(72) Inventor:
  • O'NEILL, Kim
    Provo, Utah 84604 (US)

(74) Representative: Algemeen Octrooi- en Merkenbureau B.V. 
P.O. Box 645
5600 AP Eindhoven
5600 AP Eindhoven (NL)

   


(54) TRANSGENIC MACROPHAGES, CHIMERIC ANTIGEN RECEPTORS, AND ASSOCIATED METHODS